Site icon Diseases Treatments Dictionary

Lymphogranuloma Venereum (LGV) – Causes and Treatment.

What Is Lymphogranuloma Venereum (LGV)?

Lymphogranuloma venereum (LGV) is a sexually transmitted disease (STD) caused by three strains of the bacterium chlamydia trachomatis. Some types of this bacteria cause the genital infection chlamydia. Other types of this bacteria cause LGV. Chlamydia and LGV are quite different infections. LGV causes ulcers or sores of the genital area and then invades the lymph glands in the pelvis and groin.

The most common clinical manifestation of LGV among heterosexuals is tender inguinal and/or femoral lymphadenopathy that is typically unilateral. A self-limited genital ulcer or papule sometimes occurs at the site of inoculation. However, by the time patients seek care, the lesions have often disappeared. Rectal exposure in women or men who have sex with men (MSM) can result in proctocolitis, including mucoid and/or hemorrhagic rectal discharge, anal pain, constipation, fever, and/or tenesmus. LGV is an invasive, systemic infection, and if it is not treated early, LGV proctocolitis can lead to chronic, colorectal fistulas and strictures. Genital and colorectal LGV lesions can also develop secondary bacterial infection or can be coinfected with other sexually and non-sexually transmitted pathogens.

Pathophysiology

C trachomatis is an obligate intracellular bacterium. Of the 15 known clinical serotypes, only the L1, L2, and L3 serotypes cause LGV. These serotypes are more virulent and invasive compared to other chlamydial serotypes. Infection occurs after direct contact with the skin or mucous membranes of an infected partner. The organism does not penetrate intact skin. The organism then travels by lymphatics to regional lymph nodes, where it replicates within macrophages and causes systemic disease. While transmission is predominantly sexual, cases of transmission through laboratory accidents, fomites, and nonsexual contact have been reported.

The L2b serovar has been identified to play a more important role than previously expected. After the diagnosis of 92 cases of LGV in the Netherlands among MSM, Schachter evaluated samples obtained from rectal swabs between 1979 and 1985 from patients infected with HIV in San Francisco and between 2000 and 2005 in Amsterdam. The study revealed the same serotype circulating among patients with HIV and LGV 20-25 years ago. This indicates the L2b serovar has been present and unrecognized for many years.

LGV occurs in 3 stages. The first stage, which is often unrecognized, consists of a rapidly healing, painless genital papule or pustule. The second stage, consisting of painful inguinal lymphadenopathy, occurs 2-6 weeks after the primary lesion. The third stage, which is more common in women and MSM, may have a delayed presentation and is characterized by proctocolitis.

Stages of Lymphogranuloma Venereum

The three stages of LGV infection are summarised below.

Primary infection

In the primary infection, small painless genital papules, pustules, or shallow ulcers appear on the skin. These initial lesions are transient, meaning they heal quickly and disappear. They often go unnoticed or get mistaken for genital herpes. Infected individuals tend not to seek medical help at this stage.

Secondary infection

The onset of secondary infection occurs 2–6 weeks after the primary infection.

Painful and swollen lymph glands develop in the groin area. These occur on one side (two-thirds of cases) or both sides of the groin. Buboes (inflammatory swelling of the glands around the groin) can rupture and drain pus. The ‘groove sign’ (guttering along blood vessels) occurs in 15–20% of cases. Most male patients present with symptoms during this stage. Women may present with less specific symptoms, often pelvic and back pain.

Late-stage Lymphogranuloma Venereum

Deep-seated prolonged untreated infections may lead to significant complications, including:

Causes of Lymphogranuloma Venereum

It is an infection of the urinary tract, throat and/or rectum. The main culprits of LGV are three different kinds of Chlamydia, a STD/ STI (sexually transmitted infection)

However, the same bacteria that cause genital Chlamydia does not cause LGV.  It is very common in Africa, Asia, South America, especially among men who have sex with men (MSM).

LGV is almost exclusively transmitted sexually. The bacteria enter through a moist mucosal surface – most commonly, the rectum or vagina, but infections in the penis or mouth are also possible. Like all sexually transmitted infections, anyone who has vaginal, anal and/or oral sex without using a condom can acquire LGV.

The activity with the highest risk of LGV transmission is unprotected anal intercourse. Fisting, sharing of sex toys and rectal douching can also lead to LGV transmission.

LGV can be spread even when the person with LGV has no symptoms.

Risk factors

Lymphogranuloma Venereum Symptoms

Nearly all LGV infections seen in the UK in recent years have been in the rectum.

Left untreated, LGV can cause lasting damage to the rectum that may require surgery.

LGV in the penis might cause a discharge and pain when urinating, with swollen glands in the groin.

LGV in the mouth or throat is rare but can cause swollen glands in the neck.

Possible Complications

Health problems that may result from LGV infection include:

Complications can occur many years after you are first infected.

Diagnosis of LGV

Lymphogranuloma venereum is suspected in patients who have genital ulcers, swollen inguinal lymph nodes, or proctitis and who live in, have visited, or have sexual contact with people from areas where infection is common. LGV is also suspected in patients with buboes, which may be mistaken for abscesses caused by other bacteria.

Diagnosis has usually been made by detecting antibodies to chlamydial endotoxin (complement fixation titers > 1:64 or microimmunofluorescence titers > 1:256) or by genotyping using a polymerase chain reaction-based NAAT. Antibody levels are usually elevated at presentation or shortly thereafter and remain elevated.

Direct tests for chlamydial antigens with immunoassays (eg, enzyme-linked immunosorbent assay [ELISA]) or with immunofluorescence using monoclonal antibodies to stain pus or NAATs may be available through reference laboratories (eg, Centers for Disease Control and Prevention in the US).

All sex partners should be evaluated.

After apparently successful treatment, patients should be followed for 6 months.

Treatment

Doxycycline 100 mg twice a day orally for 21 days is the recommended treatment for LGV.

Azithromycin in single‐ or multiple‐dose regimens or shorter course of doxycycline (100 mg twice a day orally for 7–14 days) has also been proposed, but consistent and concluding evidence is lacking to currently recommend these drug regimens as first‐line options. If alternative treatment regimens are used, it is advised to perform a test of cure (TOC).

This same treatment is recommended also in asymptomatic patients and contacts of LGV patients. If another regimen is used, a test of cure (TOC) must be performed.

Adjunctive Therapy

What can be done to prevent the spread of LGV?

There are a number of ways to prevent the spread of LGV:

Exit mobile version